Literature DB >> 16160853

Replacement of a conserved tyrosine by tryptophan in Gal3p of Saccharomyces cerevisiae reduces constitutive activity: implications for signal transduction in the GAL regulon.

Anirudha Lakshminarasimhan1, Paike Jayadeva Bhat.   

Abstract

The ability of Saccharomyces cerevisiae to utilize galactose is regulated by the nucleo-cytoplasmic shuttling of a transcriptional repressor, the Gal80 protein. Gal80 interacts with the transcriptional activator Gal4 in the nucleus and inhibits its function, preventing induction of the GAL genes. In response to galactose, the relative amounts of Gal80 in the cytoplasm and the nucleus are modulated by the action of a signal transducer, Gal3. Although it has been speculated that Gal3 binds galactose, this has not been experimentally demonstrated. In this study, we show that replacement of a conserved tyrosine in Gal3 by tryptophan leads to a reduction of its constitutive activity in the absence of galactose. In addition, this mutant protein was fully functional in vivo only when high concentrations of galactose were present in the medium. When overexpressed, the mutant was found to activate the genes GAL1 and GAL7/10 differentially. The implications of these findings for the fine regulation of GAL genes, and its physiological significance, are discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16160853     DOI: 10.1007/s00438-005-0031-6

Source DB:  PubMed          Journal:  Mol Genet Genomics        ISSN: 1617-4623            Impact factor:   3.291


  39 in total

Review 1.  Nuclear transport and transcription.

Authors:  A Komeili; E K O'Shea
Journal:  Curr Opin Cell Biol       Date:  2000-06       Impact factor: 8.382

Review 2.  How regulated protein translocation can produce switch-like responses.

Authors:  J E Ferrell
Journal:  Trends Biochem Sci       Date:  1998-12       Impact factor: 13.807

Review 3.  Transcriptional control of the GAL/MEL regulon of yeast Saccharomyces cerevisiae: mechanism of galactose-mediated signal transduction.

Authors:  P J Bhat; T V Murthy
Journal:  Mol Microbiol       Date:  2001-06       Impact factor: 3.501

4.  Human hepatic uridine diphosphate galactose pyrophosphorylase. Its characterization and activity during development.

Authors:  H D Abraham; R R Howell
Journal:  J Biol Chem       Date:  1969-02-25       Impact factor: 5.157

5.  Gal3p and Gal1p interact with the transcriptional repressor Gal80p to form a complex of 1:1 stoichiometry.

Authors:  David J Timson; Helen C Ross; Richard J Reece
Journal:  Biochem J       Date:  2002-05-01       Impact factor: 3.857

6.  Sites for interaction between Gal80p and Gal1p in Kluyveromyces lactis: structural model of galactokinase based on homology to the GHMP protein family.

Authors:  R A Menezes; C Amuel; R Engels; U Gengenbacher; J Labahn; C P Hollenberg
Journal:  J Mol Biol       Date:  2003-10-24       Impact factor: 5.469

7.  Poly(A) signals control both transcriptional termination and initiation between the tandem GAL10 and GAL7 genes of Saccharomyces cerevisiae.

Authors:  I H Greger; N J Proudfoot
Journal:  EMBO J       Date:  1998-08-17       Impact factor: 11.598

8.  Sequence of the Saccharomyces GAL region and its transcription in vivo.

Authors:  B A Citron; J E Donelson
Journal:  J Bacteriol       Date:  1984-04       Impact factor: 3.490

9.  The yeast galactose genetic switch is mediated by the formation of a Gal4p-Gal80p-Gal3p complex.

Authors:  A Platt; R J Reece
Journal:  EMBO J       Date:  1998-07-15       Impact factor: 11.598

Review 10.  The steroid and thyroid hormone receptor superfamily.

Authors:  R M Evans
Journal:  Science       Date:  1988-05-13       Impact factor: 47.728

View more
  1 in total

1.  The role of the local environment of engineered Tyr to Trp substitutions for probing the denaturation mechanism of FIS.

Authors:  Virginia A Muñiz; Saipraveen Srinivasan; Sarah A Boswell; Derrick W Meinhold; Tawanna Childs; Robert Osuna; Wilfredo Colón
Journal:  Protein Sci       Date:  2011-02       Impact factor: 6.725

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.